Protocol Name: Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis
Sponsor: River 3 Renal
Indication: Alport Syndrome, Focal segmental glomerulosclerosis (FSGS)
Primary Investigator: Ankit Mehta, MD
Location: Dallas Transplant Institute, 3604 Live Oak Street, Suite 100, Dallas, TX 75204